Skip to Main Content
Go to Why Work Here page
Back Bay Life Science Advisors logo

Back Bay Life Science Advisors

 Save

About Back Bay Life Science Advisors

 

Back Bay Life Science Advisors provides life science strategy and investment banking to the global life science industry, including pharma, biotech, medtech, academia, and investors.

Back Bay works with companies of all sizes across the US and global life science markets, across every stage, sector, geography, and therapeutic area. Back Bay strategy and banking teams guide companies on technology and drug development, from planning and initial concept to product commercialization, franchising and licensing, M&A, divestiture, and more. 

With headquarters in Boston's Back Bay neighborhood, Back Bay teams are staffed with MDs, PhDs, science and banking experts with proven knowledge and love for new technologies, medicines, and scientific approaches.

Why Work Here

The Greater Boston area (Boston/Cambridge/Waltham MA) is known as “the center of the nation’s biotechnology industry,” and we have been proudly based out of Boston’s Back Bay since 2010. Our approach is unique in that we among the first and only to integrate life science strategy with investment banking execution so we are a trusted partner through every stage of product development. Our strategy clients more often than not turn into our investment banking clients, as we shepherd products from clinic to development, into broad use and often through M&A needs.

We are a “boutique size” firm with global reach and reputation. We excel at guiding life science companies and their investors through complex decisions. Our teams work closely with our client partners in leading life science hubs in the United States, Europe and beyond.

Back Bay Life Science Advisors

545 Boylston Street
Boston, MA 20116
Phone: 617.236.1215

Firm Stats

President & CEO: Jonathan P. Gertler, MD
2021 Employees (All Locations): 30

Major Departments & Practices

  • Biotech
  • Pharma
  • Medical Device Strategy
  • Financing
  • M&A
  • Transactions